155 related articles for article (PubMed ID: 18386881)
1. Beta-homo-amino acid scan of angiotensin IV.
Lukaszuk A; Demaegdt H; Szemenyei E; Tóth G; Tymecka D; Misicka A; Karoyan P; Vanderheyden P; Vauquelin G; Tourwé D
J Med Chem; 2008 Apr; 51(7):2291-6. PubMed ID: 18386881
[TBL] [Abstract][Full Text] [Related]
2. The replacement of His(4) in angiotensin IV by conformationally constrained residues provides highly potent and selective analogues.
Lukaszuk A; Demaegdt H; Feytens D; Vanderheyden P; Vauquelin G; Tourwé D
J Med Chem; 2009 Sep; 52(18):5612-8. PubMed ID: 19757839
[TBL] [Abstract][Full Text] [Related]
3. Involvement of insulin-regulated aminopeptidase and/or aminopeptidase N in the angiotensin IV-induced effect on dopamine release in the striatum of the rat.
Stragier B; Demaegdt H; De Bundel D; Smolders I; Sarre S; Vauquelin G; Ebinger G; Michotte Y; Vanderheyden P
Brain Res; 2007 Feb; 1131(1):97-105. PubMed ID: 17169335
[TBL] [Abstract][Full Text] [Related]
4. Disulfide cyclized tripeptide analogues of angiotensin IV as potent and selective inhibitors of insulin-regulated aminopeptidase (IRAP).
Andersson H; Demaegdt H; Vauquelin G; Lindeberg G; Karlén A; Hallberg M; Erdélyi M; Hallberg A
J Med Chem; 2010 Nov; 53(22):8059-71. PubMed ID: 21047126
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin AT4 receptor ligand interaction with cystinyl aminopeptidase and aminopeptidase N: [125I]Angiotensin IV only binds to the cystinyl aminopeptidase apo-enzyme.
Demaegdt H; Lenaerts PJ; Swales J; De Backer JP; Laeremans H; Le MT; Kersemans K; Vogel LK; Michotte Y; Vanderheyden P; Vauquelin G
Eur J Pharmacol; 2006 Sep; 546(1-3):19-27. PubMed ID: 16919623
[TBL] [Abstract][Full Text] [Related]
6. Conformational constraints in angiotensin IV to probe the role of Tyr², Pro⁵ and Phe⁶.
Lukaszuk A; Demaegdt H; Van den Eynde I; Vanderheyden P; Vauquelin G; Tourwé D
J Pept Sci; 2011 Aug; 17(8):545-53. PubMed ID: 21538707
[TBL] [Abstract][Full Text] [Related]
7. Potent macrocyclic inhibitors of insulin-regulated aminopeptidase (IRAP) by olefin ring-closing metathesis.
Andersson H; Demaegdt H; Johnsson A; Vauquelin G; Lindeberg G; Hallberg M; Erdelyi M; Karlen A; Hallberg A
J Med Chem; 2011 Jun; 54(11):3779-92. PubMed ID: 21476495
[TBL] [Abstract][Full Text] [Related]
8. Small potent ligands to the insulin-regulated aminopeptidase (IRAP)/AT(4) receptor.
Axén A; Andersson H; Lindeberg G; Rönnholm H; Kortesmaa J; Demaegdt H; Vauquelin G; Karlén A; Hallberg M
J Pept Sci; 2007 Jul; 13(7):434-44. PubMed ID: 17559064
[TBL] [Abstract][Full Text] [Related]
9. Ligands to the (IRAP)/AT4 receptor encompassing a 4-hydroxydiphenylmethane scaffold replacing Tyr2.
Andersson H; Demaegdt H; Vauquelin G; Lindeberg G; Karlén A; Hallberg M
Bioorg Med Chem; 2008 Jul; 16(14):6924-35. PubMed ID: 18556208
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin IV displays only low affinity for native insulin-regulated aminopeptidase (IRAP).
Demaegdt H; De Backer JP; Lukaszuk A; Tóth G; Szemenyei E; Tourwé D; Vauquelin G
Fundam Clin Pharmacol; 2012 Apr; 26(2):194-7. PubMed ID: 21477268
[TBL] [Abstract][Full Text] [Related]
11. Cyclic insulin-regulated aminopeptidase (IRAP)/AT4 receptor ligands.
Axén A; Lindeberg G; Demaegdt H; Vauquelin G; Karlén A; Hallberg M
J Pept Sci; 2006 Nov; 12(11):705-13. PubMed ID: 16967438
[TBL] [Abstract][Full Text] [Related]
12. Selective labeling of IRAP by the tritiated AT(4) receptor ligand [3H]Angiotensin IV and its stable analog [3H]AL-11.
Demaegdt H; Lukaszuk A; De Buyser E; De Backer JP; Szemenyei E; Tóth G; Chakravarthy S; Panicker M; Michotte Y; Tourwé D; Vauquelin G
Mol Cell Endocrinol; 2009 Nov; 311(1-2):77-86. PubMed ID: 19643163
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity study of LVV-hemorphin-7: angiotensin AT4 receptor ligand and inhibitor of insulin-regulated aminopeptidase.
Lee J; Mustafa T; McDowall SG; Mendelsohn FA; Brennan M; Lew RA; Albiston AL; Chai SY
J Pharmacol Exp Ther; 2003 Apr; 305(1):205-11. PubMed ID: 12649370
[TBL] [Abstract][Full Text] [Related]
14. [3H]IVDE77, a novel radioligand with high affinity and selectivity for the insulin-regulated aminopeptidase.
Nikolaou A; Van den Eynde I; Tourwé D; Vauquelin G; Tóth G; Mallareddy JR; Poglitsch M; Van Ginderachter JA; Vanderheyden PM
Eur J Pharmacol; 2013 Feb; 702(1-3):93-102. PubMed ID: 23376157
[TBL] [Abstract][Full Text] [Related]
15. Binding of "AT4 receptor" ligands to insulin regulated aminopeptidase (IRAP) in intact Chinese hamster ovary cells.
Demaegdt H; Gard P; De Backer JP; Lukaszuk A; Szemenyei E; Tóth G; Tourwé D; Vauquelin G
Mol Cell Endocrinol; 2011 Jun; 339(1-2):34-44. PubMed ID: 21457753
[TBL] [Abstract][Full Text] [Related]
16. Endogenous cystinyl aminopeptidase in Chinese hamster ovary cells: characterization by [125I]Ang IV binding and catalytic activity.
Demaegdt H; Vanderheyden P; De Backer JP; Mosselmans S; Laeremans H; Le MT; Kersemans V; Michotte Y; Vauquelin G
Biochem Pharmacol; 2004 Sep; 68(5):885-92. PubMed ID: 15294451
[TBL] [Abstract][Full Text] [Related]
17. Variety of angiotensin receptors in 3T3-L1 preadipose cells and differentiated adipocytes.
Weiland F; Verspohl EJ
Horm Metab Res; 2008 Nov; 40(11):760-6. PubMed ID: 18711690
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP).
Lew RA; Mustafa T; Ye S; McDowall SG; Chai SY; Albiston AL
J Neurochem; 2003 Jul; 86(2):344-50. PubMed ID: 12871575
[TBL] [Abstract][Full Text] [Related]
19. Strain differences in the effects of angiotensin IV on mouse cognition.
Golding BJ; Overall AD; Brown G; Gard PR
Eur J Pharmacol; 2010 Sep; 641(2-3):154-9. PubMed ID: 20553916
[TBL] [Abstract][Full Text] [Related]
20. Brain and peripheral angiotensin II type 1 receptors mediate renal vasoconstrictor and blood pressure responses to angiotensin IV in the rat.
Yang R; Smolders I; De Bundel D; Fouyn R; Halberg M; Demaegdt H; Vanderheyden P; Dupont AG
J Hypertens; 2008 May; 26(5):998-1007. PubMed ID: 18398343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
